| Summer Lei Rojas, LCSW | |
|
750 N Freedom Blvd, Provo, UT 84601-1677 | |
| (801) 373-4760 | |
| (801) 373-0369 |
| Full Name | Summer Lei Rojas |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 750 N Freedom Blvd, Provo, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083844690 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6609528-3501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Summer Lei Rojas, LCSW 750 N Freedom Blvd, Provo, UT 84601-1677 Ph: (385) 225-5483 | Summer Lei Rojas, LCSW 750 N Freedom Blvd, Provo, UT 84601-1677 Ph: (801) 373-4760 |
News Archive
Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, announced today that it has signed a multi-year strategic development agreement with The University of Texas MD Anderson Cancer Center, an internationally renowned cancer research, treatment and education center.
An unusual biologically active porphyrin compound was isolated from seabed dweller Ophiura sarsii. The substance might be used as an affordable light-sensitive drug for innovative photodynamic therapy and for targeted treatment of triple-negative breast cancer and some other cancers.
Children with autism often have problems developing motor skills, such as running, throwing a ball or even learning how to write. But scientists have not known whether those difficulties run in families or are linked to autism. New research at Washington University School of Medicine in St. Louis points to autism as the culprit.
Boehringer Ingelheim and Eli Lilly and Company today announced that they have received a positive opinion from the European Medicines Agency's medicinal committee recommending approval of Jentadueto,which combines the DPP-4 inhibitor, linagliptin and metformin in a single tablet. If approved by the European Commission, linagliptin/metformin hydrochloride (HCl) will provide a new, single-tablet treatment option, taken twice-daily, for adults with Type 2 Diabetes who need to improve control of their blood glucose.
› Verified 8 days ago
Dallas Bean, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 750 N 200 W Ste 300, Provo, UT 84601 Phone: 801-373-4760 | |
Brenna Garrett, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1300 E Center St, Provo, UT 84606 Phone: 801-344-4400 | |
Mrs. Karen Dee Amsden, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 750 N Freedom Blvd, Provo, UT 84601 Phone: 801-373-4760 | |
Mr. John Paul Lilly, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 286 S 600 E, Suite C, Provo, UT 84606 Phone: 801-377-8232 Fax: 801-377-0930 | |
Frederick Brewer, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 750 N Freedom Blvd, Suite 108, Provo, UT 84601 Phone: 801-373-7394 | |
William Kory Camp, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1300 E Center St, Provo, UT 84606 Phone: 801-344-4215 | |
Alaina Barrick, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4045 N Canyon Rd, Provo, UT 84604 Phone: 859-582-0032 |